Your browser doesn't support javascript.
loading
Scopoletin from Cirsium setidens Increases Melanin Synthesis via CREB Phosphorylation in B16F10 Cells.
Ahn, Mi-Ja; Hur, Sun-Jung; Kim, Eun-Hyun; Lee, Seung Hoon; Shin, Jun Seob; Kim, Myo-Kyoung; Uchizono, James A; Whang, Wan-Kyunn; Kim, Dong-Seok.
Afiliación
  • Ahn MJ; Department of Pharmacognosy, Chung-Ang University College of Pharmacy, Seoul 156-756, Korea.
  • Hur SJ; Department of Pharmacognosy, Chung-Ang University College of Pharmacy, Seoul 156-756, Korea.
  • Kim EH; Department of Biochemistry, Chung-Ang University College of Medicine, Seoul 156-756, Korea.
  • Lee SH; Department of Biochemistry, Chung-Ang University College of Medicine, Seoul 156-756, Korea.
  • Shin JS; Department of Biochemistry, Chung-Ang University College of Medicine, Seoul 156-756, Korea.
  • Kim MK; Thomas J. Long School of Pharmacy, University of the Pacific, CA 95211, USA.
  • Uchizono JA; Thomas J. Long School of Pharmacy, University of the Pacific, CA 95211, USA.
  • Whang WK; Department of Pharmacognosy, Chung-Ang University College of Pharmacy, Seoul 156-756, Korea.
  • Kim DS; Department of Biochemistry, Chung-Ang University College of Medicine, Seoul 156-756, Korea.
Korean J Physiol Pharmacol ; 18(4): 307-11, 2014 Aug.
Article en En | MEDLINE | ID: mdl-25177162
ABSTRACT
In this study, we isolated scopoletin from Cirsium setidens Nakai (Compositae) and tested its effects on melanogenesis. Scopoletin was not toxic to cells at concentrations less than 50 µM and increased melanin synthesis in a dose-dependent manner. As melanin synthesis increased, scopoletin stimulated the total tyrosinase activity, the rate-limiting enzyme of melanogenesis. In a cell-free system, however, scopoletin did not increase tyrosinase activity, indicating that scopoletin is not a direct activator of tyrosinase. Furthermore, Western blot analysis showed that scopoletin stimulated the production of microphthalmia-associated transcription factor (MITF) and tyrosinase expression via cAMP response element-binding protein (CREB) phosphorylation in a dose-dependent manner. Based on these results, preclinical and clinical studies are needed to assess the use of scopoletin for the treatment of vitiligo.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Korean J Physiol Pharmacol Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Korean J Physiol Pharmacol Año: 2014 Tipo del documento: Article